Clicky

Dnaprint Genomics(DNAG)

Description: DNAPrint genomics, Inc. is a development-stage pharmaceutical company. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The Company generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The Company provides services that range from sequencing and genotyping to the entire process of single nucleotide polymorphisms (SNP) discovery to large industrial customers. Contract genotyping is the process of reading a genetic sequence and identifying differences in the sequence letters. This information helps researchers understand how human differences are expressed at the gene level.


Keywords: Biotechnology Pharmaceutical Biology Molecular Biology Genomics Genetics Stage Pharmaceutical DNA Genotyping Byd SNP Personal Genomics Pharmacogenomics Pharmacogenomic Single Nucleotide Polymorphism

Home Page:

1621 West University Parkway
Sarasota, FL 34243
United States
Phone: 941-366-3400


Officers

Name Title
Mr. Jatin Patel Exec. Officer
Dr. Laurence A. Rubin M.D., FRCPC FACP Exec. Officer
Mr. Naz Jiwani BBA, CIRM Exec. Officer
Ms. Pauline Gula Exec. Officer
Mr. Zach Gaskin Exec. Officer
Ms. Emanuela Charlton Exec. Officer
Ms. Lisa Tandy Herren Exec. Officer
Mr. Scot Alic Exec. Officer
Mr. Shannon Boyd Exec. Officer
Dr. Hector de Jesus Ruiz Exec. Officer

Exchange: OTCCE

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0.0003
IPO Date:
Fiscal Year End: December
Full Time Employees: 24
Back to stocks